spacer
home > > summer 2009 > ukraine: economic incentives and logistical solutions
PUBLICATIONS


Ukraine: Economic Incentives and Logistical Solutions

The global financial crisis has influenced all economic spheres, with the pharmaceutical industry and the field of clinical trials being no exception. It is well known though, that a crisis signifies new economic conditions that lead not just to threats, but also to opportunities. In particular, for medical and pharmaceutical companies, it is a good time to analyse expenses and seek possible methods of optimisation. This article suggests ways to cut laboratory expenses, with a focus on clinical trials in Ukraine.

The number of international multicentre clinical trials involving Ukrainian sites has increased significantly over the last few years. At the beginning of 2009, there were 408 active international clinical trials taking place in the country. The acute issue is the organisation of laboratory protocol for trials being conducted in Ukraine. In multicentre clinical trials, this part is usually provided by the central laboratory, as it has the advantages of more modern equipment, bigger and better quality facilities, and the ability to compare the results of samples obtained at different sites.

The use of a central lab facilitates the sponsorís monitoring procedure, as well as authorised inspections. The disadvantage of the central lab is that it may be located at some distance from certain sites. This complicates delivery of specimens and increases shipment expenses, raising the cost of this stage of the trial. The distance of the central lab also increases the turnaround time (TAT), thus adding to difficulties in organisation when the investigator must receive reports within 24 to 36 hours.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

 You must be a member of the site to make a comment.
spacer
Lidia Gomenyuk graduated from the Paediatric Department of the Ukrainian National Medical University 1997. She then undertook an internship in paediatrics between 1997 and 1998. From 1998 to 2000, she worked in the Paediatric Cardiology department of Kyiv Municipal Paediatric Hospital number 2. Between 2000 and 2002, she worked in the diagnostic department of the National Centre for Radiation Medicine. Since 2000, she has initiated and headed the Clinical Trial Unit at Dila Medical Laboratory.
spacer
Lidia Gomenyuk
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Analytical Toolbox for Cell and Gene Therapy development

We guide you through the emerging field of gene therapy developments
More info >>

White Papers

Utilising Big Data to Produce Faster and Cheaper Clinical Research

Medical Research Network (MRN) Limited

Recruitment and retention of patients remains the major challenge to ensuring trials run as fast as possible and give them the statistical power they are designed to produce. This is not just about getting better any more - but about stopping the deterioration of these metrics in modern clinical trials.
More info >>

 
Industry Events

World Vaccine Congress Europe

18-21 October 2020, Barcelona, Spain

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement